PubRank

D Felmingham

Author PubWeight™ 55.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003 2.36
2 Sterile swabs as essential equipment for rapid reliable antibiotic sensitivity tests. Med Lab Technol 1972 2.17
3 Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study. J Antimicrob Chemother 2002 2.08
4 Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Antimicrob Agents Chemother 2003 1.78
5 Teicoplanin-resistant coagulase-negative staphylococcus. Lancet 1986 1.60
6 Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. J Antimicrob Chemother 2001 1.48
7 Prophylactic oral fluconazole and candida fungaemia. Lancet 1991 1.33
8 Treatment of gonococcal urethritis in men with a rifampicin-erythromycin combination. Sex Transm Dis 1987 1.20
9 Comparative in vitro studies with 4-quinolone antimicrobials. Drugs Exp Clin Res 1985 1.19
10 The comparative in-vitro activity of twelve 4-quinolone antimicrobials against Haemophilus ducreyi. J Antimicrob Chemother 1985 1.18
11 In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial. J Antimicrob Chemother 1990 1.16
12 Contamination of blood during cardiopulmonary bypass: the effect of antibiotic prophylaxis. J Hosp Infect 1988 1.12
13 The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. Tuber Lung Dis 1992 1.11
14 The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci. J Antimicrob Chemother 1987 1.08
15 Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996. J Antimicrob Chemother 1999 1.08
16 Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg 1993 1.02
17 Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae. J Antimicrob Chemother 2005 0.99
18 The comparative in-vitro activity of ofloxacin. J Antimicrob Chemother 1988 0.99
19 Susceptibility of Streptococcus pneumoniae to penicillin, azithromycin and telithromycin (PROTEKT 1999-2003). Int J Antimicrob Agents 2005 0.93
20 Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. J Antimicrob Chemother 1988 0.92
21 Treatment of Neisseria gonorrhoeae infections in men with single-dose thiamphenicol. Sex Transm Dis 1985 0.92
22 The comparative activity of twelve 4-quinolone antimicrobials and sulphadiazine against Neisseria meningitidis. Drugs Exp Clin Res 1985 0.92
23 The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae. Drugs Exp Clin Res 1985 0.92
24 Determination of teicoplanin concentration in serum using a bioassay technique. Drugs Exp Clin Res 1987 0.91
25 Susceptibility of Pseudomonas pseudomallei to new beta-lactam and aminoglycoside antibiotics. J Antimicrob Chemother 1988 0.90
26 The in vitro activity of ramoplanin (A-16686/MDL 62,198), vancomycin and teicoplanin against methicillin-susceptible and methicillin-resistant Staphylococcus spp. Drugs Exp Clin Res 1988 0.89
27 Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996 0.88
28 Antimicrobial susceptibility of community-acquired bacterial lower respiratory tract pathogens. J Antimicrob Chemother 1996 0.86
29 In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens. Drugs Exp Clin Res 1988 0.86
30 The reliability of Entamoeba histolytica zymodemes in clinical laboratory diagnosis. Arch Invest Med (Mex) 1987 0.85
31 The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens. Drugs Exp Clin Res 1985 0.85
32 Audit of prescription and assay of aminoglycosides in a UK teaching hospital. J Antimicrob Chemother 1993 0.84
33 Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000). Braz J Infect Dis 2003 0.84
34 The serum rifabutin concentrations in a patient successfully treated for multi-resistant Mycobacterium tuberculosis infection. J Antimicrob Chemother 1990 0.83
35 Comparative in vitro activity of lomefloxacin, a difluoro-quinolone. Diagn Microbiol Infect Dis 1989 0.83
36 The in-vitro activity of grepafloxacin against Chlamydia spp., Mycoplasma spp., Ureaplasma urealyticum and Legionella spp. J Antimicrob Chemother 1997 0.82
37 In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198). J Chemother 1989 0.82
38 Equine influenza. Vet Rec 1977 0.81
39 Antimicrobial resistance of Streptococcus pneumoniae and Haemophilus influenzae in Sao Paulo, Brazil from 1996 to 2000. Int J Antimicrob Agents 2004 0.80
40 In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets. J Antimicrob Chemother 2008 0.80
41 Future trends in antimicrobial chemotherapy: expert opinion on the 43rd ICAAC. J Chemother 2004 0.80
42 Serum C-reactive protein concentrations in patients with pulmonary sarcoidosis. Thorax 1987 0.80
43 Disinfection of gastrointestinal fibrescopes: an evaluation of the Pauldrach Endocleaner, and various chemical agents. J Hosp Infect 1985 0.79
44 The in-vitro activity of doxycycline and minocycline against anaerobic bacteria. J Antimicrob Chemother 1987 0.78
45 Pharmacokinetics of orally administered ciprofloxacin in abdominal surgery. Am J Med 1989 0.78
46 In vitro activity of sulphamethoxazole/trimethoprim and sulfadoxine/pyrimethamine against Chlamydia trachomatis SA2f in McCoy cell culture. Eur J Clin Microbiol Infect Dis 1988 0.78
47 In-vitro susceptibility of Pseudomonas pseudomallei to DNA gyrase inhibitors. J Antimicrob Chemother 1987 0.78
48 In vitro activity of vancomycin and teicoplanin against anaerobic bacteria. Drugs Exp Clin Res 1987 0.78
49 The Nearchus project: antibiotic susceptibility of respiratory pathogens and clinical outcome in lower respiratory tract infections at 27 centres in the UK. Int J Antimicrob Agents 1998 0.77
50 Clinical and bacteriological efficacy of the ketolide telithromycin against isolates of key respiratory pathogens: a pooled analysis of phase III studies. Clin Microbiol Infect 2004 0.77
51 Enterococcus faecium sensitive to teicoplanin but not vancomycin. J Hosp Infect 1991 0.76
52 The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes. Drugs Exp Clin Res 1985 0.76
53 Serum and tissue levels of teicoplanin during cardiac surgery: the effect of a high dose regimen. J Antimicrob Chemother 1989 0.76
54 The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid. J Infect 1993 0.75
55 The in-vitro activities of co-amoxiclav and other oral antibiotics against Streptococcus pneumoniae isolates exhibiting intermediate susceptibility to penicillin. J Antimicrob Chemother 1998 0.75
56 Penicillin resistance in pneumococci. J Antimicrob Chemother 2000 0.75
57 Activity of thiamphenicol against Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis 1985 0.75
58 Activity of sodium fusidate in vitro against anaerobic bacteria. Eur J Clin Microbiol 1987 0.75
59 In vitro activity of aztreonam, cefuroxime and ceftazidime against gram-negative rods isolated from hospital patients with urinary tract infection. Int J Clin Pharmacol Res 1987 0.75
60 The bactericidal activity of vancomycin and teicoplanin against methicillin-resistant strains of coagulase negative Staphylococcus spp. J Antimicrob Chemother 1989 0.75
61 A high performance liquid chromatography method for the determination of FCE 22101, a novel penem antimicrobial, in serum. Drugs Exp Clin Res 1988 0.75
62 New techniques for assessing pathogenicity of quinolone-resistant bacteria. J Antimicrob Chemother 1990 0.75
63 Resistance studies with ofloxacin. J Chemother 1989 0.75
64 Treatment of gonococcal infections in men with single dose thiamphenicol. Br J Vener Dis 1983 0.75
65 Clearance of gentamicin during cardiac surgery. J Antimicrob Chemother 1995 0.75
66 Disc diffusion susceptibility testing with ceftriaxone. J Antimicrob Chemother 1994 0.75
67 In-vitro activity of the streptogramin group of antimicrobials against Corynebacterium jeikeium and D2 coryneform bacteria. J Antimicrob Chemother 1989 0.75
68 In vitro activity of teicoplanin, vancomycin, A16686, clindamycin, erythromycin and fusidic acid against anaerobic bacteria. Singapore Med J 1990 0.75
69 Antibiotic prophylaxis in cardiac surgery: factors associated with potentially toxic serum concentrations of gentamicin. J Antimicrob Chemother 1995 0.75
70 PROTEKT years 1-3 (1999-2002): study design and methodology. J Chemother 2004 0.75
71 The effect of carbon dioxide on the in vitro activity of erythromycin and RU-28965 against anaerobic bacteria. Drugs Exp Clin Res 1987 0.75